Biocair, a distinguished life science logistics company with over three decades of expertise, was announced as the winner of two awards at the esteemed Asia-Pacific Cell & Gene Therapy Excellence Awards.
The awards ceremony, held on September 14th in Singapore, shone a spotlight on outstanding pioneers, researchers, innovators and manufacturers in the cell and gene therapy field who are fostering rapid advancements in new therapies, research and development and manufacturing processes.
Cell and gene therapy, which enables personalized medicine for patients, represents a groundbreaking approach to combating diseases. These time-sensitive and transformative therapies demand logistics solutions that match their innovation.
Biocair's enduring commitment to excellence in pharmaceutical, biotech and life science logistics has earned the company prestigious accolades in two key categories:
These honors, determined by votes from the public and the CGT community, highlight the exceptional contributions of Biocair to the cell and gene therapy sector. Of particular pride is the "Supply Chain Excellence" award, acknowledging the company's impactful efforts in enhancing services for the cell and gene therapy community.
Kevin Xu, APAC General Manager at Biocair, says
“We are thrilled to be announced as winners at this industry-leading awards ceremony. We have heavily invested time and money to ensure we deliver the best service to the cell and gene community, so to be recognised for that is absolutely outstanding. I’d like to thank the whole Biocair team for their unwavering commitment to our customers and also the global scientific community for their trust in working with Biocair as we continue to move science forward together.”
Biocair's dedication to this growing sector is evident through strategic investments in cell and gene therapy logistics. The company has assembled a dedicated team of specialists offering 24-hour global support. Additionally, they have recently partnered with Trakcel to establish a chain of custody, ensuring complete visibility of orders in transit for all stakeholders.
As a firm goal, Biocair aims to be the most trusted and reliable cell and gene therapy logistics provider. To explore opportunities for collaboration and discover more about their services, please visit www.biocair.com.
--
About Biocair
Since 1986, Biocair has established a global reputation as a leading GDP logistics specialist within the pharmaceutical, biotechnology and life sciences sectors. Biocair has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled logistics services available whilst delivering flexible, tailored, cost-effective solutions to all its clients. It is committed to delivering complete end-to-end logistics solutions through its 24/7 operation and global network spanning across Europe, Africa, Asia and the Americas.
Biocair employs over 600 people worldwide and provides specialist logistics services to more than 160 countries through a global network of partners. Biocair’s offices are located in the UK, France, Belgium, Germany, USA, South Africa, China, Singapore and India.
In 2012 Biocair was acquired as an autonomous division by Geopost. Geopost is the largest parcel delivery network in Europe, which posted sales of €15.6 billion in 2022. Geopost is a holding company owned by Groupe La Poste.
For further information on Biocair, please visit www.biocair.com.
